Agenus Inc. (AGEN)

NASDAQ

$6.06

$-0.60

(-8.98%)

Regular Market

Agenus Inc. (AGEN) Live Price Chart

Last updated: ⁦2026-10-16 17:23:00⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Agenus Inc. (AGEN) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $6.06, with a market capitalisation of $293.55M and a P/E ratio of 3.29. Over the past 52 weeks, its price has ranged from $2.71 to $10.31. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$293.55M
Open	$6.65
Day's High	$1,884.00
Day's Low	$1.38
Previous Close	$6.68
Volume	538.42K
Average Volume	1.30M
P/E Ratio	3.29
52-Week High	$10.31
52-Week Low	$2.71
Dividend Yield	--
Earnings Date	--

Agenus Inc. (AGEN) Stock Price Today

Agenus Inc. (AGEN) is currently trading at $6.06 as of 2026-10-16 17:21:00, down 9.34% ($0.62) from the previous close of $6.68

During today's regular trading session, AGEN has traded between $1.38 and $1,884.00, with a trading volume of 538.42K shares. The current price is near the lower end of today's range.

Agenus Inc. (AGEN) 7-Day Stock Price Change

Over the past seven days, Agenus Inc. (AGEN) moved from $7.57 to $6.06, representing a decline of 20.00% ($1.51).

The stock traded between $6.03 and $7.79 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 920.67 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

AGEN 52-Week Price Position

Position in Range: 44.0%

52W Low$2.71

52W High$10.31

AGEN is currently trading at $6.06, placing it 44.0% of the way from its 52-week low of $2.71 to its 52-week high of $10.31. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Agenus Inc. (AGEN)?

Agenus Inc is a clinical-stage biotechnology company focused on discovering and developing immunotherapies for cancer and infectious diseases. Its primary business is immuno-oncology (I-O), where it advances antibody-based programs designed to activate innate and adaptive immunity, overcome tumor immune evasion, and expand the number of patients who may benefit from immunotherapy. The Company's clinical program includes botensilimab (BOT or AGEN1181), both as a monotherapy and in combination with balstilimab (BAL), alongside a portfolio of other clinical-stage immuno-oncology assets that may be used independently or in combination therapies. The Company operates in the United States, which contributes the majority of its revenue, as well as in other international markets.

Agenus Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	81
Exchange	NASDAQ
Company Website	https://www.agenusbio.com

How to Buy Agenus Inc. (AGEN) Stock on MEXC

Eligible investors can buy real shares of Agenus Inc. (AGEN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for AGEN and Place Your Order

Open the RealStocks trading page and search for AGEN. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Agenus Inc. (AGEN) share price today?

Agenus Inc. (AGEN) is currently trading at $ 6.06, down 9.34% ($0.62) from the previous close of $ 6.68. Intraday prices update in real time during regular trading hours.

2.Is AGEN stock going up or down today?

As of 2026-10-16 17:21:00, AGEN is trading at $ 6.06, down 9.34% ($0.62) from its previous close of $ 6.68. The stock has traded between $ 1.38 and $ 1,884.00 during today’s regular session. Past price movements do not guarantee future results.

3.What is AGEN pre-market price?

As of 2026-10-16 17:21:00, AGEN is trading at $ 6.67 in pre-market trading, down 0.22% ($0.01) from the previous close of $ 6.68. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is AGEN after-hours price?

As of 2026-10-16 17:21:00, AGEN is trading at $ 6.75 in after-hours trading, up 1.03% ($0.07) from the regular-session close of $ 6.68. After-hours prices may differ from the regular session's opening price due to lower liquidity and wider bid-ask spreads.

5.Is AGEN stock trading now?

AGEN trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does AGEN sit relative to its 52-week high and low?

Over the past 52 weeks, AGEN has traded between a low of $ 2.71 and a high of $ 10.31. At $ 6.06, the stock is positioned 44.0% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Agenus Inc. in?

Agenus Inc. (AGEN) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Agenus Inc.'s market capitalisation and where is it listed?

Agenus Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 293.55M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is AGEN valued in terms of P/E ratio and EPS?

AGEN trades at a P/E ratio of 3.29, based on trailing-twelve-month EPS of $ 2.03. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Agenus Inc. pay a dividend?

Agenus Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.